The Shyft Group Announces March 2024 Analyst & Investor Events
NOVI, Mich., March 04, 2024 (GLOBE NEWSWIRE) — The Shyft Group, Inc. (NASDAQ: SHYF) (the “Company”), the North American leader […]
Jasper Therapeutics Reports Fiscal 2023 Financial Results and Recent Corporate Developments
REDWOOD CITY, Calif., March 04, 2024 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on […]
Ethisphere Names Lincoln Electric as One of the 2024 World’s Most Ethical Companies® for the Sixth Time
CLEVELAND, March 04, 2024 (GLOBE NEWSWIRE) — Lincoln Electric Holdings Inc., (NASDAQ: LECO) has received the 2024 World’s Most Ethical […]
Indaptus Therapeutics Announces Positive Results from Second Cohort of Phase 1 Trial; Company Initiates Multi-Dose Cohort
• Positive data following completion of second cohort of Phase 1 trial of Decoy 20 leads independent Safety Review Committee […]
Velociti and Dragonfly Energy Deliver an Immediate Return on Investment with Lithium Power Systems
NEW ORLEANS, March 04, 2024 (GLOBE NEWSWIRE) — Velociti Inc., a global provider of technology deployment, maintenance and integration solutions, […]
Y-mAbs Appoints Oncology Executive Mary Tagliaferri, M.D. to its Board of Directors
NEW YORK, March 04, 2024 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical […]
Zevra Therapeutics Provides FDA Update on the PDUFA Action Date for Arimoclomol as a Treatment for Niemann-Pick Disease Type C
The new Prescription Drug User Fee Act (PDUFA) action date set by the FDA is September 21, 2024 CELEBRATION, Fla., […]
Plantify Foods Secures New Retail Chain to Sell Its Plant-Based Clean Label Products
Neve Yarak, Israel, March 04, 2024 (GLOBE NEWSWIRE) — Save Foods, Inc. (NASDAQ: SVFD) (FSE:80W) (“Save Foods”), a pioneer Agri-Food […]
The Joint Corp. to Participate in the 36th Annual Roth Conference
SCOTTSDALE, Ariz., March 04, 2024 (GLOBE NEWSWIRE) — The Joint Corp. (NASDAQ: JYNT), the nation’s largest provider of chiropractic care […]
Unicycive Therapeutics Announces Orphan Drug Designation Granted for UNI-494 by the U.S. Food and Drug Administration for the Prevention of Delayed Graft Function in Kidney Transplant Patients
LOS ALTOS, Calif., March 04, 2024 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for […]
